US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5580575A
(en)
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5305757A
(en)
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US6989141B2
(en)
*
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
US20010024638A1
(en)
*
|
1992-11-02 |
2001-09-27 |
Michel Schneider |
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
CA2063529A1
(en)
*
|
1991-03-22 |
1992-09-23 |
Katsuro Tachibana |
Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same
|
GB9106673D0
(en)
*
|
1991-03-28 |
1991-05-15 |
Hafslund Nycomed As |
Improvements in or relating to contrast agents
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
MX9205298A
(es)
*
|
1991-09-17 |
1993-05-01 |
Steven Carl Quay |
Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
|
EP0680341B1
(de)
*
|
1993-01-25 |
2001-05-09 |
Sonus Pharmaceuticals, Inc. |
Phase-Stift Kolloide zur Verwendung als Ultraschallkontrastmittel
|
IL108416A
(en)
|
1993-01-25 |
1998-10-30 |
Sonus Pharma Inc |
Colloids with phase difference as contrast ultrasound agents
|
SE504074C2
(sv)
*
|
1993-07-05 |
1996-11-04 |
Pharmacia Ab |
Proteinberedning för subkutan, intramuskulär eller intradermal administrering
|
US5798091A
(en)
|
1993-07-30 |
1998-08-25 |
Alliance Pharmaceutical Corp. |
Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
|
ES2231775T5
(es)
|
1993-07-30 |
2011-02-02 |
Imcor Pharmaceutical Co. |
Composición de microburbujas estabilizadas para ecografía.
|
US6217849B1
(en)
*
|
1993-09-29 |
2001-04-17 |
Bracco Research S.A. |
Liposome suspensions as blood pool imaging contrast agents
|
US7083572B2
(en)
*
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
CN1068229C
(zh)
*
|
1993-12-15 |
2001-07-11 |
勃勒柯研究有限公司 |
超声对比介质、含该介质的对比剂及方法
|
US5736121A
(en)
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
US5792612A
(en)
*
|
1994-06-22 |
1998-08-11 |
Helsinki University Licensing, Ltd. |
Use of lipids to improve the polymerse chain reaction
|
US5730955A
(en)
*
|
1994-08-02 |
1998-03-24 |
Molecular Biosystems, Inc. |
Process for making gas-filled microspheres containing a liquid hydrophobic barrier
|
US5540909A
(en)
*
|
1994-09-28 |
1996-07-30 |
Alliance Pharmaceutical Corp. |
Harmonic ultrasound imaging with microbubbles
|
US6743779B1
(en)
*
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6383814B1
(en)
*
|
1994-12-09 |
2002-05-07 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
USRE38971E1
(en)
|
1995-01-31 |
2006-02-07 |
Kabushiki Kaisha Toshiba |
Ultrasound diagnostic apparatus and method
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5902604A
(en)
*
|
1995-06-06 |
1999-05-11 |
Board Of Regents, The University Of Texas System |
Submicron liposome suspensions obtained from preliposome lyophilizates
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US5897851A
(en)
*
|
1995-06-07 |
1999-04-27 |
Sonus Pharmaceuticals, Inc. |
Nucleation and activation of a liquid-in-liquid emulsion for use in ultrasound imaging
|
US5804162A
(en)
*
|
1995-06-07 |
1998-09-08 |
Alliance Pharmaceutical Corp. |
Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
|
US6033645A
(en)
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
GB9511488D0
(en)
*
|
1995-06-07 |
1995-08-02 |
Nycomed Imaging As |
Improvements in or relating to contrast agents
|
US6139819A
(en)
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US6821506B2
(en)
*
|
1995-06-08 |
2004-11-23 |
Barnes-Jewish Hospital |
Site specific binding system, imaging compositions and methods
|
US5780010A
(en)
*
|
1995-06-08 |
1998-07-14 |
Barnes-Jewish Hospital |
Method of MRI using avidin-biotin conjugated emulsions as a site specific binding system
|
DE19543077C2
(de)
*
|
1995-11-13 |
1997-10-16 |
Schering Ag |
Verwendung von gashaltigen Metallkomplexen als Ultraschallkontrastmittel
|
US5840276A
(en)
*
|
1996-01-11 |
1998-11-24 |
Apfel Enterprises, Inc. |
Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis
|
EA001135B1
(ru)
*
|
1996-02-19 |
2000-10-30 |
Нюкомед Имагинг А/С |
Усовершенствования в области контрастных агентов
|
JP3956402B2
(ja)
*
|
1996-03-04 |
2007-08-08 |
日本油脂株式会社 |
アンホテリシンb運搬体
|
DK0904113T3
(da)
*
|
1996-03-05 |
2004-08-30 |
Acusphere Inc |
Mikroindkapslede fluorerede gasser til anvendelse som billeddannende midler
|
US5611344A
(en)
*
|
1996-03-05 |
1997-03-18 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
JP2947158B2
(ja)
*
|
1996-03-07 |
1999-09-13 |
昭和電工株式会社 |
ヘキサフルオロエタンの製造方法
|
AU733212B2
(en)
|
1996-03-28 |
2001-05-10 |
Board Of Trustees Of The University Of Illinois, The |
Material and methods for making improved liposome compositions
|
WO1997040679A1
(en)
*
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
EP0938299A4
(de)
*
|
1996-08-19 |
2001-01-17 |
Vivorx Pharmaceuticals Inc |
Verfahren zur herstellung von proteinpartikeln zur verabreichung pharmakologischer stoffe
|
WO1998007409A1
(en)
*
|
1996-08-23 |
1998-02-26 |
Sequus Pharmaceuticals, Inc. |
Liposomes containing a cisplatin compound
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
EP0977597B1
(de)
|
1996-09-11 |
2003-01-15 |
Imarx Pharmaceutical Corp. |
Verbesserte verfahren zur diagnostischen bilderzeugung unter verwendung eines kontrastmittels und eines vasodilators
|
DE69732308T2
(de)
*
|
1996-09-27 |
2005-06-02 |
Jagotec Ag |
Arzneistoffverabreichungssystem mit hyaluronsäure
|
DE69738406T2
(de)
*
|
1996-10-21 |
2008-12-04 |
Ge Healthcare As |
Verbesserungen in oder an Kontrastmitteln
|
DE19648664A1
(de)
*
|
1996-11-14 |
1998-05-28 |
Schering Ag |
Wirkstoffhaltige Mikropartikel, diese enthaltende Mittel, deren Verwendung zur ultraschallgesteuerten Freisetzung von Wirkstoffen sowie Verfahren zu deren Herstellung
|
GB9701237D0
(en)
*
|
1997-01-22 |
1997-03-12 |
Nycomed Imaging As |
Improvements in or relating to contrast agents
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6676626B1
(en)
|
1998-05-01 |
2004-01-13 |
Ekos Corporation |
Ultrasound assembly with increased efficacy
|
US6582392B1
(en)
|
1998-05-01 |
2003-06-24 |
Ekos Corporation |
Ultrasound assembly for use with a catheter
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6217886B1
(en)
|
1997-07-14 |
2001-04-17 |
The Board Of Trustees Of The University Of Illinois |
Materials and methods for making improved micelle compositions
|
DE69819309T2
(de)
*
|
1997-08-12 |
2004-07-15 |
Bracco Research S.A. |
Verabreichbare formulierugen und ihre anwendung in mri
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
KR100572171B1
(ko)
*
|
1997-09-29 |
2006-04-19 |
넥타르 테라퓨틱스 |
투여량 계측 흡입기용 안정화 제제
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US8668737B2
(en)
|
1997-10-10 |
2014-03-11 |
Senorx, Inc. |
Tissue marking implant
|
US7637948B2
(en)
|
1997-10-10 |
2009-12-29 |
Senorx, Inc. |
Tissue marking implant
|
JP2001520207A
(ja)
*
|
1997-10-21 |
2001-10-30 |
ニユコメド・イメージング・アクシエセルカペト |
微小血管に標的設定された造影剤および血管拡張剤による超音波造影
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
JPH11244386A
(ja)
*
|
1998-01-01 |
1999-09-14 |
Ge Yokogawa Medical Systems Ltd |
血行阻止方法及び加温装置
|
US20010003580A1
(en)
*
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
US6896659B2
(en)
*
|
1998-02-06 |
2005-05-24 |
Point Biomedical Corporation |
Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
|
US6161034A
(en)
*
|
1999-02-02 |
2000-12-12 |
Senorx, Inc. |
Methods and chemical preparations for time-limited marking of biopsy sites
|
ATE276745T1
(de)
*
|
1998-04-09 |
2004-10-15 |
Amersham Health As |
Verwendung von teilchenförmigen kontrastmitteln in der diagnostischen bilderzeugung zur untersuchung physiologischer parameter
|
US20030078227A1
(en)
*
|
1998-07-02 |
2003-04-24 |
Greenleaf James F. |
Site-directed transfection with ultrasound and cavitation nuclei
|
US7686763B2
(en)
*
|
1998-09-18 |
2010-03-30 |
University Of Washington |
Use of contrast agents to increase the effectiveness of high intensity focused ultrasound therapy
|
WO2000021578A1
(en)
*
|
1998-10-12 |
2000-04-20 |
Mallinckrodt Inc. |
Novel ultrasound contrast agents
|
US9820824B2
(en)
|
1999-02-02 |
2017-11-21 |
Senorx, Inc. |
Deployment of polysaccharide markers for treating a site within a patent
|
US8361082B2
(en)
|
1999-02-02 |
2013-01-29 |
Senorx, Inc. |
Marker delivery device with releasable plug
|
US7651505B2
(en)
*
|
2002-06-17 |
2010-01-26 |
Senorx, Inc. |
Plugged tip delivery for marker placement
|
US6725083B1
(en)
|
1999-02-02 |
2004-04-20 |
Senorx, Inc. |
Tissue site markers for in VIVO imaging
|
US20090030309A1
(en)
|
2007-07-26 |
2009-01-29 |
Senorx, Inc. |
Deployment of polysaccharide markers
|
US6862470B2
(en)
|
1999-02-02 |
2005-03-01 |
Senorx, Inc. |
Cavity-filling biopsy site markers
|
US7983734B2
(en)
|
2003-05-23 |
2011-07-19 |
Senorx, Inc. |
Fibrous marker and intracorporeal delivery thereof
|
US8498693B2
(en)
|
1999-02-02 |
2013-07-30 |
Senorx, Inc. |
Intracorporeal marker and marker delivery device
|
KR100642955B1
(ko)
|
1999-04-23 |
2006-11-10 |
알자 코포레이션 |
방출성 결합 및 그를 함유하는 조성물
|
US7238368B2
(en)
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
US6575991B1
(en)
|
1999-06-17 |
2003-06-10 |
Inrad, Inc. |
Apparatus for the percutaneous marking of a lesion
|
US6572840B1
(en)
|
1999-07-28 |
2003-06-03 |
Bristol-Myers Squibb Pharma Company |
Stable microbubbles comprised of a perfluoropropane encapsulated lipid moiety for use as an ultrasound contrast agent
|
AU6636000A
(en)
*
|
1999-08-13 |
2001-03-13 |
Point Biomedical Corporation |
Hollow microspheres with controlled fragility for medical use
|
US7510536B2
(en)
|
1999-09-17 |
2009-03-31 |
University Of Washington |
Ultrasound guided high intensity focused ultrasound treatment of nerves
|
US7520856B2
(en)
*
|
1999-09-17 |
2009-04-21 |
University Of Washington |
Image guided high intensity focused ultrasound device for therapy in obstetrics and gynecology
|
CA2385528C
(en)
|
1999-10-01 |
2013-12-10 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
EP1229839A4
(de)
|
1999-10-25 |
2005-12-07 |
Therus Corp |
Verwendung von fokusiertem ultraschall zur vaskulären abdichtung
|
US6626855B1
(en)
|
1999-11-26 |
2003-09-30 |
Therus Corpoation |
Controlled high efficiency lesion formation using high intensity ultrasound
|
US7897140B2
(en)
*
|
1999-12-23 |
2011-03-01 |
Health Research, Inc. |
Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
|
AP2002002546A0
(en)
*
|
1999-12-30 |
2002-06-30 |
Judith K Gwathmey |
Iron chelator delivery system.
|
JP2003525682A
(ja)
*
|
2000-03-06 |
2003-09-02 |
シメッド ライフ システムズ インコーポレイテッド |
超音波下で目視できる塞栓剤
|
US20020012998A1
(en)
*
|
2000-03-29 |
2002-01-31 |
Igor Gonda |
Cationic liposomes
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
PT1280520E
(pt)
|
2000-05-10 |
2014-12-16 |
Novartis Ag |
Pós à base de fosfolípidos para administração de fármacos
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
JP5078212B2
(ja)
|
2000-06-02 |
2012-11-21 |
ブラッコ・スイス・ソシエテ・アノニム |
内皮細胞を標的とするための化合物、それを含む組成物およびその使用方法
|
CA2410052A1
(en)
*
|
2000-06-02 |
2001-12-13 |
Zycos Inc. |
Delivery systems for bioactive agents
|
US6589557B2
(en)
*
|
2000-06-15 |
2003-07-08 |
Acusphere, Inc. |
Porous celecoxib matrices and methods of manufacture thereof
|
US6800297B2
(en)
|
2000-06-15 |
2004-10-05 |
Acusphere, Inc. |
Porous COX-2 inhibitor matrices and methods of manufacture thereof
|
AU7548901A
(en)
*
|
2000-06-16 |
2002-01-02 |
Sloan Kettering Inst Cancer |
Liposomal encapsulation of chelated actinium-225 and uses thereof
|
US6599441B1
(en)
*
|
2000-07-18 |
2003-07-29 |
Emerald Biostructures, Inc. |
Crystallization solutions
|
US7311893B2
(en)
*
|
2000-07-25 |
2007-12-25 |
Neurochem (International) Limited |
Amyloid targeting imaging agents and uses thereof
|
EP1919388B1
(de)
|
2000-11-20 |
2012-12-26 |
Senorx, Inc. |
Gewebestellemarker für in vivo bilddarstellungen
|
ES2260321T3
(es)
*
|
2000-12-07 |
2006-11-01 |
Universiteit Utrecht Holding B.V. |
Composicion para el tratamiento de transtornos inflamatorios.
|
US7179449B2
(en)
*
|
2001-01-30 |
2007-02-20 |
Barnes-Jewish Hospital |
Enhanced ultrasound detection with temperature-dependent contrast agents
|
US20030211045A1
(en)
*
|
2001-02-05 |
2003-11-13 |
Danuta Leszcyznska |
Magnetoliposome composition for targeted treatment of biological tissue and associated methods
|
US7897141B2
(en)
*
|
2002-04-01 |
2011-03-01 |
Drexel University |
Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
|
WO2002078611A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Drexel University |
Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
|
AU2002320348B2
(en)
*
|
2001-07-10 |
2007-07-19 |
Sonogene, Llc |
Enhancement of transfection of DNA into the liver
|
US20030215391A1
(en)
*
|
2001-07-19 |
2003-11-20 |
Carlos Rabito |
Fluorescent agents for real-time measurement of organ function
|
US20030044354A1
(en)
*
|
2001-08-16 |
2003-03-06 |
Carpenter Alan P. |
Gas microsphere liposome composites for ultrasound imaging and ultrasound stimulated drug release
|
US7344702B2
(en)
|
2004-02-13 |
2008-03-18 |
Bristol-Myers Squibb Pharma Company |
Contrast agents for myocardial perfusion imaging
|
US20050065118A1
(en)
*
|
2001-10-16 |
2005-03-24 |
Jing Wang |
Organosulfur inhibitors of tyrosine phosphatases
|
AU2002359576A1
(en)
|
2001-12-03 |
2003-06-17 |
Ekos Corporation |
Catheter with multiple ultrasound radiating members
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
US6850804B2
(en)
|
2002-01-18 |
2005-02-01 |
Calfacior Corporation |
System method and apparatus for localized heating of tissue
|
US7048756B2
(en)
|
2002-01-18 |
2006-05-23 |
Apasara Medical Corporation |
System, method and apparatus for evaluating tissue temperature
|
US6993394B2
(en)
|
2002-01-18 |
2006-01-31 |
Calfacion Corporation |
System method and apparatus for localized heating of tissue
|
US7407778B2
(en)
*
|
2002-02-07 |
2008-08-05 |
Pettegrew Jay W |
Compounds, compositions and methods for treating neuropsychiatric disorders
|
US7700074B2
(en)
*
|
2002-02-07 |
2010-04-20 |
Pettegrew Jay W |
Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
|
CA2513044A1
(en)
*
|
2002-03-01 |
2004-08-05 |
Dyax Corp. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
US7261876B2
(en)
|
2002-03-01 |
2007-08-28 |
Bracco International Bv |
Multivalent constructs for therapeutic and diagnostic applications
|
US20050250700A1
(en)
*
|
2002-03-01 |
2005-11-10 |
Sato Aaron K |
KDR and VEGF/KDR binding peptides
|
US7211240B2
(en)
*
|
2002-03-01 |
2007-05-01 |
Bracco International B.V. |
Multivalent constructs for therapeutic and diagnostic applications
|
US7794693B2
(en)
|
2002-03-01 |
2010-09-14 |
Bracco International B.V. |
Targeting vector-phospholipid conjugates
|
US7985402B2
(en)
*
|
2002-03-01 |
2011-07-26 |
Bracco Suisse Sa |
Targeting vector-phospholipid conjugates
|
US7666979B2
(en)
*
|
2002-03-01 |
2010-02-23 |
Bracco International B.V. |
Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
|
ES2506142T3
(es)
|
2002-03-01 |
2014-10-13 |
Dyax Corp. |
Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico
|
US8623822B2
(en)
|
2002-03-01 |
2014-01-07 |
Bracco Suisse Sa |
KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
|
AU2003224808A1
(en)
*
|
2002-03-28 |
2003-10-13 |
Imcor Pharmaceutical Company |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US7462366B2
(en)
|
2002-03-29 |
2008-12-09 |
Boston Scientific Scimed, Inc. |
Drug delivery particle
|
US7094369B2
(en)
*
|
2002-03-29 |
2006-08-22 |
Scimed Life Systems, Inc. |
Processes for manufacturing polymeric microspheres
|
US8226629B1
(en)
|
2002-04-01 |
2012-07-24 |
Ekos Corporation |
Ultrasonic catheter power control
|
DE10214983A1
(de)
*
|
2002-04-04 |
2004-04-08 |
TransMIT Gesellschaft für Technologietransfer mbH |
Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
|
US7923029B2
(en)
*
|
2002-04-11 |
2011-04-12 |
Medimmune Llc |
Spray freeze dry of compositions for pulmonary administration
|
WO2003086443A1
(en)
*
|
2002-04-11 |
2003-10-23 |
Medimmune Vaccines, Inc. |
Spray freeze dry of compositions for intranasal administration
|
US8829198B2
(en)
*
|
2007-10-31 |
2014-09-09 |
Proteotech Inc |
Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
|
US20050152962A1
(en)
*
|
2002-06-12 |
2005-07-14 |
Metselaar Josbert M. |
Composition for treatment of inflammatory disorders
|
EP1371362A1
(de)
*
|
2002-06-12 |
2003-12-17 |
Universiteit Utrecht Holding B.V. |
Zusammensetzung zur Behandlung entzündlicher Erkrankungen
|
CA2492339A1
(en)
|
2002-06-12 |
2003-12-24 |
Boston Scientific Limited |
Bulking agents
|
CA2490692A1
(en)
|
2002-06-27 |
2004-01-08 |
Health Research, Inc. |
Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
|
AU2003249742A1
(en)
*
|
2002-07-02 |
2004-01-23 |
Health Research, Inc. |
Efficient synthesis of pyropheophorbide a and its derivatives
|
US20040076582A1
(en)
*
|
2002-08-30 |
2004-04-22 |
Dimatteo Kristian |
Agent delivery particle
|
US7842377B2
(en)
|
2003-08-08 |
2010-11-30 |
Boston Scientific Scimed, Inc. |
Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
|
EP1393720A1
(de)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesikel enthaltend Corticosteroide zur Behandlung von Krebs
|
US8012454B2
(en)
|
2002-08-30 |
2011-09-06 |
Boston Scientific Scimed, Inc. |
Embolization
|
US7198867B2
(en)
*
|
2002-09-17 |
2007-04-03 |
Diffusion Science, Inc. |
Electrochemical generation, storage and reaction of hydrogen and oxygen
|
US6921371B2
(en)
|
2002-10-14 |
2005-07-26 |
Ekos Corporation |
Ultrasound radiating members for catheter
|
US7883490B2
(en)
|
2002-10-23 |
2011-02-08 |
Boston Scientific Scimed, Inc. |
Mixing and delivery of therapeutic compositions
|
US20060036158A1
(en)
|
2003-11-17 |
2006-02-16 |
Inrad, Inc. |
Self-contained, self-piercing, side-expelling marking apparatus
|
US20050053666A1
(en)
*
|
2002-12-31 |
2005-03-10 |
Stelios Tzannis |
Antibody-containing particles and compositions
|
PT2949658T
(pt)
|
2003-03-03 |
2018-10-18 |
Bracco Suisse Sa |
Péptidos que ligam especificamente o recetor de hgf (cmet) e utilizações dos mesmos
|
US20040258761A1
(en)
*
|
2003-03-20 |
2004-12-23 |
Wheatley Margaret A. |
Polymer-based microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
|
US20060198882A1
(en)
*
|
2003-03-21 |
2006-09-07 |
Yechezkel Barenholz |
Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
|
US20040248877A1
(en)
*
|
2003-04-30 |
2004-12-09 |
Sandeep Gupta |
Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof
|
US20040242886A1
(en)
*
|
2003-04-30 |
2004-12-02 |
Sandeep Gupta |
Monocyclic diazodioxide based Bcl-2 protein antagonists related applications
|
WO2004110350A2
(en)
*
|
2003-05-14 |
2004-12-23 |
Torreypines Therapeutics, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
US7877133B2
(en)
|
2003-05-23 |
2011-01-25 |
Senorx, Inc. |
Marker or filler forming fluid
|
US20060257842A1
(en)
*
|
2003-05-29 |
2006-11-16 |
Pettegrew Jay W |
Cryopreservation media and molecules
|
DE602004022301D1
(de)
*
|
2003-05-29 |
2009-09-10 |
Jay W Pettegrew |
Glycerophosphocholin und derivate davon zur medizinischen abbildung von neuropsychiatrischen erkrankungen
|
US20090227647A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Thomas Lake |
Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes
|
US20100331380A1
(en)
*
|
2009-06-29 |
2010-12-30 |
Esposito Luke A |
Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies
|
US8916598B2
(en)
|
2003-05-30 |
2014-12-23 |
Proteotech Inc |
Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies
|
US7057100B2
(en)
*
|
2003-06-26 |
2006-06-06 |
The J.C. Robinson Seed Co. |
Inbred corn line W23129
|
US7358226B2
(en)
*
|
2003-08-27 |
2008-04-15 |
The Regents Of The University Of California |
Ultrasonic concentration of drug delivery capsules
|
US7976823B2
(en)
|
2003-08-29 |
2011-07-12 |
Boston Scientific Scimed, Inc. |
Ferromagnetic particles and methods
|
US20050106101A1
(en)
*
|
2003-10-31 |
2005-05-19 |
Ajay Purohit |
Novel chemical agents comprising an adenosine moiety or an adenosine analog moiety and an imaging moiety and methods of their use
|
US7901770B2
(en)
|
2003-11-04 |
2011-03-08 |
Boston Scientific Scimed, Inc. |
Embolic compositions
|
US20050273002A1
(en)
|
2004-06-04 |
2005-12-08 |
Goosen Ryan L |
Multi-mode imaging marker
|
US20080287560A1
(en)
*
|
2004-12-31 |
2008-11-20 |
Loh Roland R |
Polymer foams containing multi-functional layered nano-graphite
|
US9359481B2
(en)
*
|
2003-11-26 |
2016-06-07 |
Owens Corning Intellectual Capital, Llc |
Thermoplastic foams and method of forming them using nano-graphite
|
US8568632B2
(en)
*
|
2003-11-26 |
2013-10-29 |
Owens Corning Intellectual Capital, Llc |
Method of forming thermoplastic foams using nano-particles to control cell morphology
|
US8206299B2
(en)
|
2003-12-16 |
2012-06-26 |
University Of Washington |
Image guided high intensity focused ultrasound treatment of nerves
|
PL1718283T3
(pl)
|
2004-01-22 |
2013-08-30 |
Univ Miami |
Miejscowe preparaty koenzymu Q10 i sposoby ich zastosowania
|
US7201737B2
(en)
|
2004-01-29 |
2007-04-10 |
Ekos Corporation |
Treatment of vascular occlusions using elevated temperatures
|
US7341569B2
(en)
*
|
2004-01-30 |
2008-03-11 |
Ekos Corporation |
Treatment of vascular occlusions using ultrasonic energy and microbubbles
|
WO2005090370A1
(en)
*
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
US7736671B2
(en)
|
2004-03-02 |
2010-06-15 |
Boston Scientific Scimed, Inc. |
Embolization
|
US8173176B2
(en)
|
2004-03-30 |
2012-05-08 |
Boston Scientific Scimed, Inc. |
Embolization
|
US7485283B2
(en)
|
2004-04-28 |
2009-02-03 |
Lantheus Medical Imaging |
Contrast agents for myocardial perfusion imaging
|
JP2007538103A
(ja)
|
2004-05-20 |
2007-12-27 |
ザ スクリップス リサーチ インスティテュート |
トランスサイレチン安定化
|
US7311861B2
(en)
|
2004-06-01 |
2007-12-25 |
Boston Scientific Scimed, Inc. |
Embolization
|
US8012457B2
(en)
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
US7306716B2
(en)
*
|
2004-06-16 |
2007-12-11 |
Access Business Group International Llc |
Water treatment system
|
JP2008503490A
(ja)
*
|
2004-06-17 |
2008-02-07 |
センジェント・セラピューティクス・インコーポレイテッド |
チロシンホスファターゼの三置換窒素調節物質
|
US20060135483A1
(en)
*
|
2004-07-09 |
2006-06-22 |
Cheruvallath Zacharia S |
Oxygen/nitrogen heterocycle inhibitors of tyrosine phosphatases
|
US9066679B2
(en)
|
2004-08-31 |
2015-06-30 |
University Of Washington |
Ultrasonic technique for assessing wall vibrations in stenosed blood vessels
|
WO2006028970A1
(en)
|
2004-09-02 |
2006-03-16 |
Cengent Therapeutics, Inc. |
Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases
|
EP1793919A4
(de)
*
|
2004-09-03 |
2009-12-23 |
Imarx Therapeutics Inc |
Vorrichtung und verfahren zur herstellung einer mikrosphärenbildenden zusammensetzung
|
US8611189B2
(en)
*
|
2004-09-16 |
2013-12-17 |
University of Washington Center for Commercialization |
Acoustic coupler using an independent water pillow with circulation for cooling a transducer
|
JP5001843B2
(ja)
|
2004-09-17 |
2012-08-15 |
ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ |
α−シヌクレイン毒性を阻害する化合物、組成物および方法
|
US20060067889A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Light Sciences Corporation |
Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents
|
EP1809246B1
(de)
*
|
2004-10-08 |
2008-07-16 |
Alza Corporation |
Verfahren zur einführung eines lipid-verknüpften teils in eine vorgeformte lipidanordnung mit mikrowellen
|
US8425550B2
(en)
|
2004-12-01 |
2013-04-23 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
PL2730277T3
(pl)
|
2004-12-22 |
2020-06-15 |
Nitto Denko Corporation |
Nośnik leku i zestaw z nośnikiem leku do hamowania włóknienia
|
US20120269886A1
(en)
|
2004-12-22 |
2012-10-25 |
Nitto Denko Corporation |
Therapeutic agent for pulmonary fibrosis
|
CN100427142C
(zh)
*
|
2005-01-10 |
2008-10-22 |
重庆海扶(Hifu)技术有限公司 |
一种高强度聚焦超声治疗用助剂及其筛选方法
|
ATE531389T1
(de)
*
|
2005-01-28 |
2011-11-15 |
Univ Northwest |
Lipid- und distickstoffoxidverbindung als hilfsmittel zur erhöhung der impfstoffeffizienz
|
US7858183B2
(en)
|
2005-03-02 |
2010-12-28 |
Boston Scientific Scimed, Inc. |
Particles
|
US7727555B2
(en)
|
2005-03-02 |
2010-06-01 |
Boston Scientific Scimed, Inc. |
Particles
|
US8153435B1
(en)
|
2005-03-30 |
2012-04-10 |
Tracer Detection Technology Corp. |
Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
|
WO2006130217A2
(en)
*
|
2005-04-01 |
2006-12-07 |
The Regents Of The University Of California |
Substituted phosphate esters of nucleoside phosphonates
|
WO2006137953A1
(en)
|
2005-04-01 |
2006-12-28 |
The Regents Of The Univerisity Of California |
Phosphono-pent-2-en-1-yl nucleosides and analogs
|
EP1874197A4
(de)
*
|
2005-04-12 |
2010-02-10 |
Ekos Corp |
Ultraschallkatheter mit kavitationsfördernder oberfläche
|
EP1714642A1
(de)
*
|
2005-04-18 |
2006-10-25 |
Bracco Research S.A. |
Pharmazeutische Formulierung mit gasgefüllten Mikrokapseln zur ultraschallgesteuerten Freisetzung
|
US10357328B2
(en)
|
2005-04-20 |
2019-07-23 |
Bard Peripheral Vascular, Inc. and Bard Shannon Limited |
Marking device with retractable cannula
|
US7963287B2
(en)
|
2005-04-28 |
2011-06-21 |
Boston Scientific Scimed, Inc. |
Tissue-treatment methods
|
AU2005332157A1
(en)
*
|
2005-05-23 |
2006-11-30 |
Mebiopharm Co., Ltd., |
Method of producing liposomes containing gas enclosed therein
|
WO2006129099A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Cancercure Technology As |
Ultrasound treatment system
|
WO2007002109A2
(en)
*
|
2005-06-20 |
2007-01-04 |
The Regents Of The University Of California |
Multidentate pyrone-derived chelators for medicinal imaging and chelation
|
US9463426B2
(en)
|
2005-06-24 |
2016-10-11 |
Boston Scientific Scimed, Inc. |
Methods and systems for coating particles
|
US7824659B2
(en)
|
2005-08-10 |
2010-11-02 |
Lantheus Medical Imaging, Inc. |
Methods of making radiolabeled tracers and precursors thereof
|
EP1921976A2
(de)
|
2005-08-12 |
2008-05-21 |
University of Washington |
Verfahren und gerät zur vorbereitung von organen und geweben für eine laparoskopische operation
|
US8518069B2
(en)
|
2005-09-07 |
2013-08-27 |
Cabochon Aesthetics, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US10548659B2
(en)
|
2006-01-17 |
2020-02-04 |
Ulthera, Inc. |
High pressure pre-burst for improved fluid delivery
|
US9358033B2
(en)
|
2005-09-07 |
2016-06-07 |
Ulthera, Inc. |
Fluid-jet dissection system and method for reducing the appearance of cellulite
|
US9011473B2
(en)
|
2005-09-07 |
2015-04-21 |
Ulthera, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US9486274B2
(en)
|
2005-09-07 |
2016-11-08 |
Ulthera, Inc. |
Dissection handpiece and method for reducing the appearance of cellulite
|
US9187608B2
(en)
*
|
2005-09-08 |
2015-11-17 |
Owens Corning Intellectual Capital, Llc |
Polystyrene foam containing a modifier-free nanoclay and having improved fire protection performance
|
WO2007035529A2
(en)
|
2005-09-16 |
2007-03-29 |
University Of Washington |
Thin-profile therapeutic ultrasound applicators
|
US8492428B2
(en)
*
|
2005-09-20 |
2013-07-23 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
US8016757B2
(en)
|
2005-09-30 |
2011-09-13 |
University Of Washington |
Non-invasive temperature estimation technique for HIFU therapy monitoring using backscattered ultrasound
|
CA2562580C
(en)
|
2005-10-07 |
2014-04-29 |
Inrad, Inc. |
Drug-eluting tissue marker
|
US8007509B2
(en)
|
2005-10-12 |
2011-08-30 |
Boston Scientific Scimed, Inc. |
Coil assemblies, components and methods
|
US8167805B2
(en)
|
2005-10-20 |
2012-05-01 |
Kona Medical, Inc. |
Systems and methods for ultrasound applicator station keeping
|
US8257338B2
(en)
*
|
2006-10-27 |
2012-09-04 |
Artenga, Inc. |
Medical microbubble generation
|
US20080195036A1
(en)
*
|
2005-12-02 |
2008-08-14 |
Cabochon Aesthetics, Inc. |
Devices and methods for selectively lysing cells
|
US9248317B2
(en)
*
|
2005-12-02 |
2016-02-02 |
Ulthera, Inc. |
Devices and methods for selectively lysing cells
|
US20080014627A1
(en)
*
|
2005-12-02 |
2008-01-17 |
Cabochon Aesthetics, Inc. |
Devices and methods for selectively lysing cells
|
US20080200864A1
(en)
*
|
2005-12-02 |
2008-08-21 |
Cabochon Aesthetics, Inc. |
Devices and methods for selectively lysing cells
|
US7885793B2
(en)
|
2007-05-22 |
2011-02-08 |
International Business Machines Corporation |
Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
|
WO2007070827A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Bristol-Myers Squibb Pharma Company |
Contrast agents for myocardium perfusion imaging
|
US8152839B2
(en)
|
2005-12-19 |
2012-04-10 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
US8101197B2
(en)
|
2005-12-19 |
2012-01-24 |
Stryker Corporation |
Forming coils
|
US7947368B2
(en)
|
2005-12-21 |
2011-05-24 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
US9572886B2
(en)
|
2005-12-22 |
2017-02-21 |
Nitto Denko Corporation |
Agent for treating myelofibrosis
|
US8138361B2
(en)
*
|
2005-12-28 |
2012-03-20 |
The Trustees Of The University Of Pennsylvania |
C-10 carbamates of taxanes
|
WO2007087418A2
(en)
*
|
2006-01-24 |
2007-08-02 |
Imarx Therapeutics, Inc. |
Composition and method for neuromuscular blockade
|
US20070184085A1
(en)
*
|
2006-02-03 |
2007-08-09 |
Boston Scientific Scimed, Inc. |
Ultrasound activated medical device
|
US20070184076A1
(en)
*
|
2006-02-07 |
2007-08-09 |
Unger Evan C |
Liquid-filled nanodroplets for anti-cancer therapy
|
EP2013182B1
(de)
|
2006-03-13 |
2013-09-04 |
Kyorin Pharmaceutical Co., Ltd. |
Aminochinolone als gsk-3-hemmer
|
US20100273776A1
(en)
*
|
2006-03-29 |
2010-10-28 |
FOLDRx PHARMACEUTICALS, INC |
Inhibition of alpha-synuclein toxicity
|
EP2015846A2
(de)
|
2006-04-24 |
2009-01-21 |
Ekos Corporation |
Ultraschalltherapiesystem
|
AU2007244705A1
(en)
*
|
2006-04-27 |
2007-11-08 |
Barnes-Jewish Hospital |
Detection and imaging of target tissue
|
WO2007137236A2
(en)
*
|
2006-05-19 |
2007-11-29 |
Drexel University |
Drug loaded contrast agents: combining diagnosis and therapy
|
BRPI0716088B8
(pt)
|
2006-08-28 |
2021-05-25 |
Kyowa Hakko Kirin Co Ltd |
anticorpo isolado, composição, molécula de ácido nucléico isolada, vetor, método para produzir um anticorpo, hibridoma, e, kit
|
US20070080613A1
(en)
*
|
2006-09-20 |
2007-04-12 |
Sterlite Optical Technologies Ltd |
Storage and transportation device for storing and transporting optical fiber preform and precursors thereof
|
KR20090068263A
(ko)
|
2006-09-21 |
2009-06-25 |
액티브스 바이오사이언시즈, 인크. |
세린 가수분해효소 억제제
|
AU2007310949A1
(en)
|
2006-10-19 |
2008-04-24 |
Auspex Pharmaceuticals, Inc. |
Substituted indoles
|
US8064987B2
(en)
|
2006-10-23 |
2011-11-22 |
C. R. Bard, Inc. |
Breast marker
|
US8414927B2
(en)
|
2006-11-03 |
2013-04-09 |
Boston Scientific Scimed, Inc. |
Cross-linked polymer particles
|
US20100137421A1
(en)
*
|
2006-11-08 |
2010-06-03 |
Emmanuel Theodorakis |
Small molecule therapeutics, synthesis of analogues and derivatives and methods of use
|
US9579077B2
(en)
|
2006-12-12 |
2017-02-28 |
C.R. Bard, Inc. |
Multiple imaging mode tissue marker
|
ES2432572T3
(es)
|
2006-12-18 |
2013-12-04 |
C.R. Bard, Inc. |
Marcador de biopsia con propiedades de obtención de imágenes generadas in situ
|
EP2121676A1
(de)
|
2006-12-19 |
2009-11-25 |
Auspex Pharmaceuticals, Inc. |
Herstellung und nutzen von ccr5-inhibitoren
|
EP2125739A1
(de)
*
|
2006-12-22 |
2009-12-02 |
Encysive Pharmaceuticals, Inc. |
Modulatoren des c3a-rezeptors und verfahren zu deren anwendung
|
US10182833B2
(en)
|
2007-01-08 |
2019-01-22 |
Ekos Corporation |
Power parameters for ultrasonic catheter
|
WO2008106167A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases
|
AU2008219622A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Conatus Pharmaceuticals, Inc. |
Methods for the treatment of liver diseases using specified matrix metalloproteinase (MMP) inhibitors
|
HUE031070T2
(en)
|
2007-03-15 |
2017-06-28 |
Auspex Pharmaceuticals Inc |
Deuterated d9-venlafaxine
|
AU2008228764B2
(en)
|
2007-03-22 |
2014-05-08 |
Berg Llc |
Topical formulations having enhanced bioavailability
|
US20080242752A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Yadollah Delaviz |
Polystyrene foams incorporating nanographite and HFC-134
|
TWI407971B
(zh)
*
|
2007-03-30 |
2013-09-11 |
Nitto Denko Corp |
Cancer cells and tumor-related fibroblasts
|
WO2008128115A2
(en)
*
|
2007-04-13 |
2008-10-23 |
Somaxon Pharmaceuticals, Inc. |
Low-dose doxepin formulations
|
US7892776B2
(en)
|
2007-05-04 |
2011-02-22 |
The Regents Of The University Of California |
Screening assay to identify modulators of protein kinase A
|
EP2494932B1
(de)
|
2007-06-22 |
2020-05-20 |
Ekos Corporation |
Vorrichtung zur Behandlung von intrakranialen Blutungen
|
US8247423B2
(en)
*
|
2007-07-12 |
2012-08-21 |
Tragara Pharmaceuticals, Inc. |
Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
|
EP2203458B1
(de)
*
|
2007-09-11 |
2011-11-02 |
Kyorin Pharmaceutical Co., Ltd. |
Cyanoaminochinolone als gsk-3-inhibitoren
|
BRPI0816814B1
(pt)
|
2007-09-12 |
2021-08-31 |
Kyorin Pharmaceutical Co. Ltd |
Composto, composição farmacêutica e uso de um composto
|
US20090264421A1
(en)
*
|
2007-10-05 |
2009-10-22 |
Bible Keith C |
Methods and Compositions for Treating Cancer
|
US8439940B2
(en)
|
2010-12-22 |
2013-05-14 |
Cabochon Aesthetics, Inc. |
Dissection handpiece with aspiration means for reducing the appearance of cellulite
|
CA2706465A1
(en)
|
2007-11-21 |
2009-05-28 |
Pharmaxis Ltd. |
Haloallylamine inhibitors of ssao/vap-1 and uses therefor
|
JP2011506432A
(ja)
*
|
2007-12-10 |
2011-03-03 |
エピターゲット・アーエス |
非ラメラ形成脂質を含む音響感受性薬物送達粒子
|
US20090151241A1
(en)
*
|
2007-12-14 |
2009-06-18 |
Dressler Lawrence V |
Method for producing algae in photobioreactor
|
WO2009099767A2
(en)
|
2008-01-31 |
2009-08-13 |
C.R. Bard, Inc. |
Biopsy tissue marker
|
EP2257315B1
(de)
|
2008-02-29 |
2019-10-23 |
Lantheus Medical Imaging, Inc. |
Kontrastmittel für anwendungen einschliesslich perfusionsbildgebung
|
KR101601997B1
(ko)
|
2008-03-17 |
2016-03-17 |
암비트 바이오사이언시즈 코포레이션 |
Raf 키나아제 조절제로서의 퀴나졸린 유도체 및 그의 사용방법
|
WO2009126764A1
(en)
|
2008-04-11 |
2009-10-15 |
Cytotech Labs, Llc |
Methods and use of inducing apoptosis in cancer cells
|
US8197857B2
(en)
*
|
2008-06-06 |
2012-06-12 |
Dressler Lawrence V |
Method for eliminating carbon dioxide from waste gases
|
GB0811856D0
(en)
|
2008-06-27 |
2008-07-30 |
Ucl Business Plc |
Magnetic microbubbles, methods of preparing them and their uses
|
US20110070154A1
(en)
*
|
2008-08-13 |
2011-03-24 |
Hyde Roderick A |
Artificial cells
|
CN101658533A
(zh)
*
|
2008-08-29 |
2010-03-03 |
首都医科大学宣武医院 |
抗肿瘤药物的干细胞递送
|
US9327061B2
(en)
|
2008-09-23 |
2016-05-03 |
Senorx, Inc. |
Porous bioabsorbable implant
|
WO2010040772A2
(en)
*
|
2008-10-07 |
2010-04-15 |
Bracco Research Sa |
Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same
|
WO2010077244A1
(en)
|
2008-12-30 |
2010-07-08 |
C.R. Bard Inc. |
Marker delivery device for tissue marker placement
|
WO2010088450A2
(en)
|
2009-01-30 |
2010-08-05 |
Celladon Corporation |
Methods for treating diseases associated with the modulation of serca
|
US20100204570A1
(en)
*
|
2009-02-06 |
2010-08-12 |
Paul Lubock |
Anchor markers
|
US8568793B2
(en)
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
KR20110124787A
(ko)
|
2009-02-27 |
2011-11-17 |
암비트 바이오사이언시즈 코포레이션 |
Jak 키나아제 조절 퀴나졸린 유도체 및 이의 사용 방법
|
WO2010101967A2
(en)
|
2009-03-04 |
2010-09-10 |
Idenix Pharmaceuticals, Inc. |
Phosphothiophene and phosphothiazole hcv polymerase inhibitors
|
MX2011009414A
(es)
*
|
2009-03-11 |
2011-10-19 |
Kyorin Seiyaku Kk |
7-cicloalquiloaminoquinolonas como inhibidores de gsk-3.
|
JP2012520314A
(ja)
|
2009-03-11 |
2012-09-06 |
アムビト ビオスシエンセス コルポラチオン |
癌治療のためのインダゾリルアミノピロロトリアジンとタキサンの併用
|
JP2012520731A
(ja)
*
|
2009-03-20 |
2012-09-10 |
インキューブ ラブズ, エルエルシー |
固形薬物送達装置、処方物および使用法
|
WO2010110686A1
(en)
|
2009-03-27 |
2010-09-30 |
Pathway Therapeutics Limited |
Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
|
EP2411387B1
(de)
|
2009-03-27 |
2015-08-19 |
VetDC, Inc. |
Pyrimidinyl- und 1,3,5-triazinyl-benzimidazol-sulfonamide und ihre verwendung in der krebstherapie
|
LT2419096T
(lt)
|
2009-04-15 |
2020-04-10 |
Lantheus Medical Imaging, Inc. |
Radiofarmacinės kompozicijos stabilizavimas naudojant askorbo rūgštį
|
DK2421829T3
(en)
|
2009-04-22 |
2016-01-04 |
Axikin Pharmaceuticals Inc |
2,5-disubstituted aryl sulfonamide CCR3 antagonists
|
PE20120811A1
(es)
|
2009-04-22 |
2012-07-08 |
Axikin Pharmaceuticals Inc |
Antagonistas ccr3 arilsulfonamida
|
EP2421830B1
(de)
|
2009-04-22 |
2014-04-02 |
Axikin Pharmaceuticals, Inc. |
2,5-Disubstituierte Arylsulfonamide als CCR3-Antagonisten
|
KR20180018833A
(ko)
|
2009-05-11 |
2018-02-21 |
베르그 엘엘씨 |
외대사 변환인자, 다차원 세포내 분자 또는 환경 영향인자를 사용하여 종양성 장애를 치료하는 방법
|
DE102009031274A1
(de)
|
2009-06-30 |
2011-01-13 |
Justus-Liebig-Universität Giessen |
Liposomen zur pulmonalen Applikation
|
WO2011003870A2
(en)
|
2009-07-06 |
2011-01-13 |
Creabilis S.A. |
Mini-pegylated corticosteroids, compositions including same, and methods of making and using same
|
ES2706185T3
(es)
|
2009-07-07 |
2019-03-27 |
Mei Pharma Inc |
Pirimidinil y 1,3,5-triazinil bencimidazoles y sus usos en la terapia contra el cáncer
|
CA2767168C
(en)
|
2009-07-08 |
2019-04-09 |
Hope Medical Enterprises, Inc. D.B.A. Hope Pharmaceuticals |
Sodium thiosulfate-containing pharmaceutical compositions
|
US8404728B2
(en)
|
2009-07-30 |
2013-03-26 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
TW201117812A
(en)
|
2009-08-05 |
2011-06-01 |
Idenix Pharmaceuticals Inc |
Macrocyclic serine protease inhibitors
|
US9358064B2
(en)
|
2009-08-07 |
2016-06-07 |
Ulthera, Inc. |
Handpiece and methods for performing subcutaneous surgery
|
US11096708B2
(en)
|
2009-08-07 |
2021-08-24 |
Ulthera, Inc. |
Devices and methods for performing subcutaneous surgery
|
US20130035326A1
(en)
|
2009-08-19 |
2013-02-07 |
Ambit Biosciences Corporation |
Biaryl compounds and methods of use thereof
|
WO2011029094A2
(en)
|
2009-09-04 |
2011-03-10 |
The University Of North Carolina At Chapel Hill |
Systems, methods, and computer readable media for high- frequency contrast imaging and image-guided therapeutics
|
US9107950B2
(en)
|
2009-09-15 |
2015-08-18 |
The Trustees Of Columbia University In The City Of New York |
Systems, methods, and devices for microbubbles
|
US8469904B2
(en)
|
2009-10-12 |
2013-06-25 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US20110118600A1
(en)
|
2009-11-16 |
2011-05-19 |
Michael Gertner |
External Autonomic Modulation
|
US8986211B2
(en)
|
2009-10-12 |
2015-03-24 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US8517962B2
(en)
|
2009-10-12 |
2013-08-27 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US20160059044A1
(en)
|
2009-10-12 |
2016-03-03 |
Kona Medical, Inc. |
Energy delivery to intraparenchymal regions of the kidney to treat hypertension
|
US9119951B2
(en)
|
2009-10-12 |
2015-09-01 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US20110092880A1
(en)
|
2009-10-12 |
2011-04-21 |
Michael Gertner |
Energetic modulation of nerves
|
US8986231B2
(en)
|
2009-10-12 |
2015-03-24 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US9174065B2
(en)
|
2009-10-12 |
2015-11-03 |
Kona Medical, Inc. |
Energetic modulation of nerves
|
US8295912B2
(en)
|
2009-10-12 |
2012-10-23 |
Kona Medical, Inc. |
Method and system to inhibit a function of a nerve traveling with an artery
|
TW201120037A
(en)
*
|
2009-10-26 |
2011-06-16 |
Sunesis Pharmaceuticals Inc |
Compounds and methods for treatment of cancer
|
WO2011056764A1
(en)
|
2009-11-05 |
2011-05-12 |
Ambit Biosciences Corp. |
Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
|
WO2011057214A2
(en)
|
2009-11-09 |
2011-05-12 |
Neurogenetic Pharmaceuticals, Inc. |
Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor
|
WO2011069002A1
(en)
|
2009-12-02 |
2011-06-09 |
Alquest Therapeutics, Inc. |
Organoselenium compounds and uses thereof
|
EP2513113B1
(de)
|
2009-12-18 |
2018-08-01 |
Idenix Pharmaceuticals LLC |
Auf 5,5-kondensiertem arylen oder heteroarylen basierende hepatitis-c-virus-hemmer
|
US8710092B2
(en)
*
|
2009-12-23 |
2014-04-29 |
Map Pharmaceuticals, Inc. |
Substituted indolo 4,3 FG quinolines useful for treating migraine
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
PT2534136T
(pt)
|
2010-02-08 |
2017-12-15 |
Lantheus Medical Imaging Inc |
Métodos para sintetizar agentes de imagiologia, e seus intermediários
|
DK2542542T3
(en)
|
2010-03-02 |
2015-07-20 |
Axikin Pharmaceuticals Inc |
ISOTOPIC ENRICHED ARYL SULPHONAMIDE CCR3 ANTAGONISTS
|
WO2011112689A2
(en)
|
2010-03-11 |
2011-09-15 |
Ambit Biosciences Corp. |
Saltz of an indazolylpyrrolotriazine
|
SG183508A1
(en)
*
|
2010-03-12 |
2012-10-30 |
Berg Pharma Llc |
Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
|
TW201134820A
(en)
|
2010-03-17 |
2011-10-16 |
Axikin Pharmaceuticals Inc |
Arylsulfonamide CCR3 antagonists
|
JP5735488B2
(ja)
*
|
2010-04-09 |
2015-06-17 |
株式会社日立製作所 |
超音波診断治療装置
|
US9296722B2
(en)
|
2010-05-27 |
2016-03-29 |
Ambit Biosciences Corporation |
Azolyl urea compounds and methods of use thereof
|
WO2011150201A2
(en)
|
2010-05-27 |
2011-12-01 |
Ambit Biosciences Corporation |
Azolyl amide compounds and methods of use thereof
|
WO2011153197A1
(en)
|
2010-06-01 |
2011-12-08 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
|
CA2801003A1
(en)
|
2010-06-01 |
2011-12-08 |
Biotheryx, Inc. |
Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone
|
AU2011265047B2
(en)
|
2010-06-07 |
2014-10-23 |
Novomedix, Llc |
Furanyl compounds and the use thereof
|
CA2805745C
(en)
|
2010-07-19 |
2019-01-15 |
Summa Health System |
Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease
|
ITPI20100095A1
(it)
*
|
2010-07-28 |
2012-01-29 |
Giuseppe Sabino |
Un mezzo di contrasto ecografico antigene-specifico, un procedimento per la sua preparazione e suoi usi.
|
WO2012030914A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Boisciences Corporation |
4-azolylaminoquinazoline derivatives and methods of use thereof
|
WO2012030912A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
7-cyclylquinazoline derivatives and methods of use thereof
|
EP2611793A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
2-cyclochinazolinderivate und verwendungsverfahren dafür
|
US8633207B2
(en)
|
2010-09-01 |
2014-01-21 |
Ambit Biosciences Corporation |
Quinazoline compounds and methods of use thereof
|
WO2012030924A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Azolopyridine and azolopyrimidine compounds and methods of use thereof
|
EP2611795B1
(de)
|
2010-09-01 |
2016-05-04 |
Ambit Biosciences Corporation |
Optisch aktives pyrazolylaminochinazolin sowie pharmazeutische zusammensetzungen und verwendungsverfahren dafür
|
KR20130141469A
(ko)
|
2010-09-01 |
2013-12-26 |
암비트 바이오사이언시즈 코포레이션 |
피라졸릴아미노퀴나졸린의 브롬화수소 염
|
WO2012030918A1
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Adenosine a3 receptor modulating compounds and methods of use thereof
|
EP2611812A1
(de)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Thienopyridin- und thienopyrimidinverbindungen sowie verfahren zu ihrer verwendung
|
WO2012030944A2
(en)
|
2010-09-01 |
2012-03-08 |
Ambit Biosciences Corporation |
Quinoline and isoquinoline compounds and methods of use thereof
|
WO2012044641A1
(en)
|
2010-09-29 |
2012-04-05 |
Pathway Therapeutics Inc. |
1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
|
US9427410B2
(en)
*
|
2010-10-08 |
2016-08-30 |
The University Of North Carolina At Chapel Hill |
Formulation of acoustically activatable particles having low vaporization energy and methods for using same
|
WO2012051090A1
(en)
|
2010-10-11 |
2012-04-19 |
Axikin Pharmaceuticals, Inc. |
Salts of arylsulfonamide ccr3 antagonists
|
JP2014500275A
(ja)
|
2010-12-06 |
2014-01-09 |
フォリカ,インコーポレイテッド |
禿頭症を治療するため、および毛髪の成長を促進するための方法
|
WO2012080050A1
(en)
|
2010-12-14 |
2012-06-21 |
F. Hoffmann-La Roche Ag |
Solid forms of a phenoxybenzenesulfonyl compound
|
US9540443B2
(en)
|
2011-01-26 |
2017-01-10 |
Kolltan Pharmaceuticals, Inc. |
Anti-kit antibodies
|
CA2825152A1
(en)
|
2011-01-31 |
2012-08-09 |
Celgene Corporation |
Pharmaceutical compositions of cytidine analogs and methods of use thereof
|
US9353100B2
(en)
|
2011-02-10 |
2016-05-31 |
Idenix Pharmaceuticals Llc |
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
|
KR101940831B1
(ko)
|
2011-03-28 |
2019-01-21 |
메이 파마, 아이엔씨. |
(알파-치환된 아르알킬아미노 및 헤테로아릴알킬아미노)피리미딘일 및 1,3,5-트라이아진일 벤즈이미다졸, 이들을 함유하는 약학 조성물, 및 증식성 질병의 치료에 사용하기 위한 이들 화합물
|
EP2691388A1
(de)
|
2011-03-28 |
2014-02-05 |
MEI Pharma, Inc. |
(kondensierte arylamino- und heterocyclylamino-)pyrimidynyl und 1,3,5-triazinyl-benzimidazole, pharmazeutische zusammensetzungen daraus und ihre verwendung zur behandlung von proliferativen erkrankungen
|
BR112013024909A2
(pt)
|
2011-03-28 |
2019-09-24 |
Mei Pharma Inc |
composto, composição farmacêutica, método para o tratamento, prevenção ou melhoria de um ou mais sintomas de desordem, doença, ou condição mediada por pi3k, e método para modular a atividade enzimática de pi3k
|
US20120252721A1
(en)
|
2011-03-31 |
2012-10-04 |
Idenix Pharmaceuticals, Inc. |
Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
|
ES2762451T3
(es)
|
2011-04-04 |
2020-05-25 |
Berg Llc |
Tratamiento de tumores del sistema nervioso central con coenzima Q10
|
WO2012136813A2
(en)
|
2011-04-07 |
2012-10-11 |
Universitetet I Oslo |
Agents for medical radar diagnosis
|
PE20140628A1
(es)
|
2011-06-17 |
2014-05-30 |
Berg Llc |
Composiciones farmaceuticas inhalables
|
WO2012177962A1
(en)
|
2011-06-23 |
2012-12-27 |
Map Pharmaceuticals, Inc. |
Novel fluoroergoline analogs
|
WO2013037482A1
(en)
|
2011-09-15 |
2013-03-21 |
Phenex Pharmaceuticals Ag |
Farnesoid x receptor agonists for cancer treatment and prevention
|
US8822549B2
(en)
*
|
2011-10-13 |
2014-09-02 |
Jennifer L. Johnson |
Buffered oxygen therapeutic
|
TWI650321B
(zh)
|
2011-10-14 |
2019-02-11 |
美商安比特生物科學公司 |
雜環化合物及其使用方法
|
US9057712B1
(en)
|
2011-10-27 |
2015-06-16 |
Copilot Ventures Fund Iii Llc |
Methods of delivery of encapsulated perfluorocarbon taggants
|
US8592445B2
(en)
|
2011-12-19 |
2013-11-26 |
Map Pharmaceuticals, Inc. |
Iso-ergoline derivatives
|
SG10201506202RA
(en)
|
2011-12-21 |
2015-09-29 |
Map Pharmaceuticals Inc |
Novel neuromodulatory compounds
|
WO2013130600A1
(en)
|
2012-02-29 |
2013-09-06 |
Ambit Biosciences Corporation |
Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith
|
US9365556B2
(en)
|
2012-03-16 |
2016-06-14 |
Axikin Pharmaceuticals, Inc. |
3,5-diaminopyrazole kinase inhibitors
|
WO2013163675A1
(en)
|
2012-05-02 |
2013-11-07 |
Pharmaxis Ltd. |
Substituted 3-haloallylamine inhibitors of ssao and uses thereof
|
WO2013187965A1
(en)
|
2012-06-14 |
2013-12-19 |
Mayo Foundation For Medical Education And Research |
Pyrazole derivatives as inhibitors of stat3
|
US9012640B2
(en)
|
2012-06-22 |
2015-04-21 |
Map Pharmaceuticals, Inc. |
Cabergoline derivatives
|
MX354719B
(es)
*
|
2012-06-26 |
2018-03-16 |
Ge Healthcare As |
Preparacion de una composicion que comprende microburbujas de gas.
|
BR112015001459B1
(pt)
|
2012-07-25 |
2023-02-14 |
Celldex Therapeutics, Inc |
Anticorpo isolado ou fragmento do mesmo, conjugado, usos dos mesmos, composição farmacêutica, polinucleotídeo, vetor, célula hospedeira, célula isolada, kit, método in vitro para inibir atividade da kit, método para produzir um anticorpo
|
CN103565745A
(zh)
|
2012-08-10 |
2014-02-12 |
德克萨斯州大学系统董事会 |
用于治疗中风的神经保护性脂质体组合物和方法
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
US9074186B2
(en)
|
2012-08-15 |
2015-07-07 |
Boston Medical Center Corporation |
Production of red blood cells and platelets from stem cells
|
EP2892884A1
(de)
|
2012-09-07 |
2015-07-15 |
Axikin Pharmaceuticals, Inc. |
Isotopisch angereicherte arylsulfonamid-ccr3-antagonisten
|
WO2014055647A1
(en)
|
2012-10-03 |
2014-04-10 |
Mei Pharma, Inc. |
(sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
|
US9982290B2
(en)
|
2012-10-04 |
2018-05-29 |
The University Of North Carolina At Chapel Hill |
Methods and systems for using encapsulated microbubbles to process biological samples
|
EP2916830A2
(de)
|
2012-11-08 |
2015-09-16 |
Summa Health System |
Kombinationen aus vitamin c, vitamin k und einem polyphenol zur wundheilung
|
CA2892227C
(en)
|
2012-11-30 |
2020-12-15 |
Novomedix, Llc |
Substituted biaryl sulfonamides and the use thereof
|
US9169214B2
(en)
|
2012-12-21 |
2015-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
|
JP2016503795A
(ja)
|
2012-12-21 |
2016-02-08 |
マップ ファーマシューティカルズ インコーポレイテッド |
新規メチセルジド誘導体
|
EP2943188A1
(de)
|
2013-01-11 |
2015-11-18 |
Mayo Foundation for Medical Education and Research |
Vitamine c und k zur behandlung polyzystischer erkrankungen
|
US9101745B2
(en)
|
2013-03-14 |
2015-08-11 |
Sonogene Llc |
Sonochemical induction of ABCA1 expression and compositions therefor
|
JP6625966B2
(ja)
|
2013-03-15 |
2019-12-25 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
希ガスが豊富な液体ならびにその調製及び使用の方法
|
BR112015025424A2
(pt)
|
2013-04-08 |
2017-07-18 |
Berg Llc |
tratamento de câncer usando terapias de combinação de coenzima q10
|
CA2914369C
(en)
|
2013-06-06 |
2023-02-14 |
Igenica Biotherapeutics, Inc. |
Anti-c10orf54 antibodies and uses thereof
|
EP3039021A1
(de)
|
2013-08-30 |
2016-07-06 |
Ambit Biosciences Corporation |
Biaryl-acetamid-verbindungen und verfahren zur verwendung davon
|
AU2014315186B2
(en)
|
2013-09-04 |
2020-02-27 |
Berg Llc |
Methods of treatment of cancer by continuous infusion of coenzyme Q10
|
NZ631142A
(en)
|
2013-09-18 |
2016-03-31 |
Axikin Pharmaceuticals Inc |
Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
|
WO2015042375A1
(en)
|
2013-09-20 |
2015-03-26 |
Idenix Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
USD715442S1
(en)
|
2013-09-24 |
2014-10-14 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD715942S1
(en)
|
2013-09-24 |
2014-10-21 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD716451S1
(en)
|
2013-09-24 |
2014-10-28 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD716450S1
(en)
|
2013-09-24 |
2014-10-28 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
EP3110974A4
(de)
|
2014-02-24 |
2018-01-24 |
Celgene Corporation |
Verfahren zur verwendung eines aktivators von cereblon für neuronale zellexpansion und behandlung von erkrankungen des zentralnervensystems
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
US20170066779A1
(en)
|
2014-03-05 |
2017-03-09 |
Idenix Pharmaceuticals Llc |
Solid forms of a flaviviridae virus inhibitor compound and salts thereof
|
AU2015231202B9
(en)
|
2014-03-20 |
2019-10-24 |
Capella Therapeutics, Inc. |
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer
|
CA2943231C
(en)
|
2014-03-20 |
2023-10-24 |
Capella Therapeutics, Inc. |
Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer
|
US9968758B2
(en)
*
|
2014-03-21 |
2018-05-15 |
Boston Scientific Scimed, Inc. |
Devices and methods for treating a lung
|
MX2016014731A
(es)
|
2014-05-12 |
2017-05-04 |
Conatus Pharmaceuticals Inc |
Tratamiento de las complicaciones de la enfermedad cronica del higado con enfermedades de caspasa.
|
US10155818B2
(en)
|
2014-05-28 |
2018-12-18 |
Agenus Inc. |
Anti-GITR antibodies and methods of use thereof
|
WO2015195474A1
(en)
|
2014-06-18 |
2015-12-23 |
Biotheryx, Inc. |
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
|
GB201411423D0
(en)
|
2014-06-26 |
2014-08-13 |
Ge Healthcare As |
Lipid sterilisation method
|
US9499514B2
(en)
|
2014-07-11 |
2016-11-22 |
Celgene Corporation |
Antiproliferative compounds and methods of use thereof
|
JP6543342B2
(ja)
|
2014-08-14 |
2019-07-10 |
アルハマドシャー,マモウン,エム. |
血清半減期を延長するための、調節可能リンカーを介した薬学的活性剤とトランスサイレチンリガンドのコンジュゲーション
|
JP2017526713A
(ja)
|
2014-09-12 |
2017-09-14 |
トビラ セラピューティクス, インコーポレイテッド |
線維症を処置するためのセニクリビロック併用療法
|
US20170354639A1
(en)
|
2014-10-24 |
2017-12-14 |
Biogen Ma Inc. |
Diterpenoid derivatives and methods of use thereof
|
US10925579B2
(en)
|
2014-11-05 |
2021-02-23 |
Otsuka Medical Devices Co., Ltd. |
Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery
|
US10500227B2
(en)
*
|
2014-12-03 |
2019-12-10 |
University Of Cincinnati |
Bioactive gas-encapsulated echogenic liposomes and methods for treating cardiovascular disease
|
KR20170087500A
(ko)
|
2014-12-11 |
2017-07-28 |
피에르 파브르 메디카먼트 |
항-c10orf54 항체들 및 그들의 용도들
|
JP7211703B2
(ja)
|
2014-12-22 |
2023-01-24 |
ザ ロックフェラー ユニバーシティー |
抗mertkアゴニスト抗体及びその使用
|
MY191736A
(en)
|
2014-12-23 |
2022-07-13 |
Axikin Pharmaceuticals Inc |
3,5-diaminopyrazole kinase inhibitors
|
WO2016109400A2
(en)
|
2014-12-31 |
2016-07-07 |
Lantheus Medical Imaging, Inc. |
Lipid-encapsulated gas microsphere compositions and related methods
|
WO2016118541A1
(en)
|
2015-01-20 |
2016-07-28 |
Xoc Pharmaceuticals, Inc |
Ergoline compounds and uses thereof
|
AU2016209490B2
(en)
|
2015-01-20 |
2020-09-03 |
Xoc Pharmaceuticals, Inc. |
Isoergoline compounds and uses thereof
|
EP3250572B1
(de)
|
2015-01-28 |
2020-08-26 |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. |
Substituierte imidazo[1,2-a]pyridin-2-ylamin-verbindungen und pharmazeutische zusammensetzungen sowie verfahren zur verwendung davon
|
AU2016227493B2
(en)
|
2015-03-03 |
2022-01-20 |
Kymab Limited |
Antibodies, uses & methods
|
LT3303394T
(lt)
|
2015-05-29 |
2020-10-12 |
Agenus Inc. |
Anti-ctla-4 antikūnai ir jų naudojimo būdai
|
EP3307388B1
(de)
|
2015-06-10 |
2022-06-22 |
Ekos Corporation |
Ultraschallkatheter
|
CN104984338A
(zh)
*
|
2015-06-23 |
2015-10-21 |
重庆医科大学 |
笑气作为细胞内超声空化效应增强剂的应用
|
JP6919099B2
(ja)
|
2015-06-23 |
2021-08-18 |
ニューロクライン バイオサイエンシーズ,インコーポレイテッド |
神経学的疾患または障害を処置するためのvmat2阻害剤
|
PE20181322A1
(es)
|
2015-09-01 |
2018-08-14 |
Agenus Inc |
Anticuerpo anti-pd1 y sus metodos de uso
|
ES2857085T3
(es)
|
2015-10-30 |
2021-09-28 |
Neurocrine Biosciences Inc |
Ditosilato de valbenazina y polimorfos del mismo
|
WO2017079566A1
(en)
|
2015-11-05 |
2017-05-11 |
Conatus Pharmaceuticals, Inc. |
Caspase inhibitors for use in the treatment of liver cancer
|
US10112924B2
(en)
|
2015-12-02 |
2018-10-30 |
Astraea Therapeutics, Inc. |
Piperdinyl nociceptin receptor compounds
|
SI3394057T1
(sl)
|
2015-12-23 |
2022-06-30 |
Neurocrine Biosciences, Inc. |
Sintetičen postopek za pripravo (S)-(2R,3R,11bR)-3-izobutil-9,10-dimetoksi-2,3,4,6,7,11b-heksahidro-1H- pirido(2,1,-a)izokinolin-2-il 2-amino-3-metilbutanoat di(4-metilbenzensulfonata)
|
SG11201805480TA
(en)
|
2015-12-31 |
2018-07-30 |
Conatus Pharmaceuticals Inc |
Methods of using caspase inhibitors in treatment of liver disease
|
EP3399981B1
(de)
|
2016-01-08 |
2023-08-02 |
Celgene Corporation |
Feste formen von 2-(4-chlorphenyl)-n-((2-2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl)-2,2-difluoracetamid sowie deren pharmazeutische zusammensetzungen und verwendungen
|
US9938254B2
(en)
|
2016-01-08 |
2018-04-10 |
Celgene Corporation |
Antiproliferative compounds, and their pharmaceutical compositions and uses
|
US10960013B2
(en)
|
2016-03-04 |
2021-03-30 |
East Carolina University |
J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders
|
JP2019510085A
(ja)
|
2016-03-08 |
2019-04-11 |
ロス ガトス ファーマスーティカルズ, インク.Los Gatos Pharmaceuticals, Inc. |
癌治療のためのナノ粒子ならびに方法および化合物
|
WO2017156183A1
(en)
|
2016-03-08 |
2017-09-14 |
Los Gatos Pharmaceuticals, Inc. |
Camptothecin derivatives and uses thereof
|
AU2017250086A1
(en)
|
2016-04-11 |
2018-09-20 |
Clexio Biosciences Ltd. |
Deuterated ketamine derivatives
|
WO2017180794A1
(en)
|
2016-04-13 |
2017-10-19 |
Skyline Antiinfectives, Inc. |
Deuterated o-sulfated beta-lactam hydroxamic acids and deuterated n-sulfated beta-lactams
|
AU2017260532A1
(en)
*
|
2016-05-04 |
2018-11-22 |
Lantheus Medical Imaging, Inc. |
Methods and devices for preparation of ultrasound contrast agents
|
ES2939373T3
(es)
|
2016-05-13 |
2023-04-21 |
Pasteur Institut |
Inhibición de los receptores de acetilcolina nicotínicos beta-2 para tratar la patología de la enfermedad de Alzheimer
|
TWI753910B
(zh)
|
2016-05-16 |
2022-02-01 |
美商拜歐斯瑞克斯公司 |
吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
|
KR102543118B1
(ko)
|
2016-05-27 |
2023-06-14 |
아게누스 인코포레이티드 |
항-tim-3 항체 및 이의 사용 방법
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
EP3481864A1
(de)
|
2016-07-08 |
2019-05-15 |
Staten Biotechnology B.V. |
Anti-apoc3-antikörper und verfahren zur verwendung davon
|
WO2018035281A1
(en)
|
2016-08-17 |
2018-02-22 |
North Carolina State University |
Northern-southern route to synthesis of bacteriochlorins
|
MA46285A
(fr)
|
2016-09-19 |
2019-07-31 |
Mei Pharma Inc |
Polythérapie
|
US10844119B2
(en)
|
2016-10-11 |
2020-11-24 |
Agenus Inc. |
Anti-LAG-3 antibodies and methods of use thereof
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
KR102539159B1
(ko)
|
2016-11-07 |
2023-06-02 |
주식회사 뉴라클사이언스 |
서열 유사성을 가진 항-패밀리 19, 멤버 a5 항체 및 그것의 사용 방법
|
US10106521B2
(en)
|
2016-11-09 |
2018-10-23 |
Phloronol, Inc. |
Eckol derivatives, methods of synthesis and uses thereof
|
AU2017356926B2
(en)
|
2016-11-09 |
2024-01-04 |
Novomedix, Llc |
Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use
|
US10836774B2
(en)
|
2016-11-30 |
2020-11-17 |
North Carolina State University |
Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds
|
EP3548007A4
(de)
|
2016-12-01 |
2020-08-12 |
Ignyta, Inc. |
Verfahren zur behandlung von krebs
|
TW202345829A
(zh)
|
2016-12-02 |
2023-12-01 |
美商紐羅克里生物科學有限公司 |
戊苯那嗪(valbenazine)於治療精神分裂症或情感性精神分裂症之用途
|
CN110300599A
(zh)
|
2016-12-07 |
2019-10-01 |
艾吉纳斯公司 |
抗体和其使用方法
|
IL307242A
(en)
|
2016-12-07 |
2023-11-01 |
Agenus Inc |
Anti-CTLA-4 antibodies and methods of using them
|
CA3051834A1
(en)
|
2017-01-27 |
2018-08-02 |
Neurocrine Bioscienes, Inc. |
Methods for the administration of certain vmat2 inhibitors
|
NZ755597A
(en)
|
2017-02-17 |
2023-06-30 |
Eidos Therapeutics Inc |
Processes for preparing ag-10, its intermediates, and salts thereof
|
US10961276B2
(en)
|
2017-02-17 |
2021-03-30 |
CAMRIS International, Inc. |
Universal antivenom
|
WO2018164996A1
(en)
|
2017-03-06 |
2018-09-13 |
Neurocrine Biosciences, Inc. |
Dosing regimen for valbenazine
|
SG11201908678XA
(en)
|
2017-03-27 |
2019-10-30 |
Celgene Corp |
Methods and compositions for reduction of immunogenicity
|
JP7297672B2
(ja)
|
2017-04-13 |
2023-06-26 |
アジェナス インコーポレイテッド |
抗cd137抗体およびその使用方法
|
WO2018193427A1
(en)
|
2017-04-21 |
2018-10-25 |
Staten Biotechnology B.V. |
Anti-apoc3 antibodies and methods of use thereof
|
US20200179352A1
(en)
|
2017-04-26 |
2020-06-11 |
Neurocrine Biosciences, Inc. |
Use of valbenazine for treating levodopa-induced dyskinesia
|
HUE062927T2
(hu)
|
2017-05-01 |
2023-12-28 |
Agenus Inc |
Anti-TIGIT ellenanyagok és alkalmazási eljárásaik
|
JOP20190219A1
(ar)
|
2017-05-09 |
2019-09-22 |
Cardix Therapeutics LLC |
تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية
|
US10085999B1
(en)
|
2017-05-10 |
2018-10-02 |
Arixa Pharmaceuticals, Inc. |
Beta-lactamase inhibitors and uses thereof
|
CA3064274A1
(en)
|
2017-06-01 |
2018-12-06 |
Xoc Pharmaceuticals, Inc. |
Ergoline derivatives for use in medicine
|
EP3645040A4
(de)
|
2017-06-27 |
2021-05-05 |
Neuracle Science Co., Ltd |
Verwendung von anti-fam19a5-antikörpern zur krebsbehandlung
|
KR102511122B1
(ko)
|
2017-06-27 |
2023-03-22 |
주식회사 뉴라클사이언스 |
녹내장의 치료를 위한 항-서열 유사성 19를 가진 패밀리, 멤버 a5 항체의 용도
|
AU2018291082A1
(en)
|
2017-06-27 |
2020-01-16 |
Neuracle Science Co., Ltd. |
Anti-FAM19A5 antibodies and uses thereof
|
KR102573257B1
(ko)
|
2017-06-27 |
2023-09-01 |
주식회사 뉴라클사이언스 |
섬유증의 치료를 위한 항-fam19a5 항체의 용도
|
AU2018324070B2
(en)
|
2017-09-01 |
2023-05-18 |
East Carolina University |
Compounds, compositions, kits, and methods for activating immune cells and/or an immune system response
|
IL309802A
(en)
|
2017-09-21 |
2024-02-01 |
Neurocrine Biosciences Inc |
High dose valbenazine formulation and related preparations, methods and kits
|
CN116492340A
(zh)
|
2017-10-10 |
2023-07-28 |
纽罗克里生物科学有限公司 |
施用某些vmat2抑制剂的方法
|
US10993941B2
(en)
|
2017-10-10 |
2021-05-04 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
JP7039694B2
(ja)
|
2017-10-31 |
2022-03-22 |
スターテン・バイオテクノロジー・ベー・フェー |
抗apoc3抗体およびその使用方法
|
WO2019139869A1
(en)
|
2018-01-10 |
2019-07-18 |
Cura Therapeutics Llc |
Pharmaceutical compositions comprising phenylsulfonamides, and their therapeutic applications
|
TW201929847A
(zh)
|
2018-01-10 |
2019-08-01 |
美商克拉治療有限責任公司 |
包含二羧酸之醫藥組合物及其治療應用
|
KR102245539B1
(ko)
*
|
2018-02-12 |
2021-04-29 |
주식회사 지앤피바이오사이언스 |
코어-쉘 구조의 마이크로 입자를 유효성분으로 포함하는 성장인자 유전자 발현 증가용 조성물
|
WO2019183463A1
(en)
|
2018-03-23 |
2019-09-26 |
Eidos Therapeutics, Inc. |
Methods of treating ttr amyloidosis using ag10
|
WO2019191557A1
(en)
*
|
2018-03-29 |
2019-10-03 |
Case Wester Reserve University |
Stabilized nanobubbles and microbubbles for diagnostic and therapeutic applications
|
CN112424223A
(zh)
|
2018-04-24 |
2021-02-26 |
纽洛可科学有限公司 |
抗序列相似家族19成员a5的抗体在治疗神经性疼痛中的用途
|
WO2019241555A1
(en)
|
2018-06-14 |
2019-12-19 |
Neurocrine Biosciences, Inc. |
Vmat2 inhibitor compounds, compositions, and methods relating thereto
|
EP3814327A1
(de)
|
2018-06-29 |
2021-05-05 |
Histogen, Inc. |
(s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorphenoxy)pentansäure-derivate und verwandte verbindungen als caspase-inhibitoren zur behandlung kardiovaskulärer erkrankungen
|
JP2021531007A
(ja)
|
2018-07-20 |
2021-11-18 |
ピエール、ファーブル、メディカマン |
Vistaに対する受容体
|
EP3836926A4
(de)
|
2018-08-15 |
2022-05-04 |
Neurocrine Biosciences, Inc. |
Verfahren zur verabreichung bestimmter vmat2-inhibitoren
|
MA53238A
(fr)
|
2018-08-17 |
2022-04-13 |
Eidos Therapeutics Inc |
Formules d'ag10
|
CN112969503A
(zh)
|
2018-10-03 |
2021-06-15 |
斯塔滕生物技术有限公司 |
对人类和食蟹猕猴apoc3具有特异性的抗体和其使用方法
|
CN113365650A
(zh)
|
2018-11-16 |
2021-09-07 |
新免疫技术有限公司 |
用il-7蛋白和免疫检查点抑制剂的组合治疗肿瘤的方法
|
KR20200071198A
(ko)
|
2018-12-10 |
2020-06-19 |
네오이뮨텍, 인코퍼레이티드 |
Nrf2 발현 조절 기반 T 세포 항암면역치료법
|
US20230078755A1
(en)
|
2018-12-19 |
2023-03-16 |
Shy Therapeutics, Llc |
Compounds that Interact with the RAS Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease
|
CN109602450B
(zh)
*
|
2019-01-29 |
2021-04-30 |
北京大学第三医院(北京大学第三临床医学院) |
一种超声腔内探头隔离及导声一体化装置
|
EP3921038A1
(de)
|
2019-02-06 |
2021-12-15 |
Dice Alpha, Inc. |
Il-17a modulators and uses thereof
|
MA55080A
(fr)
|
2019-02-26 |
2022-01-05 |
Inspirna Inc |
Anticorps anti-mertk à affinité élevée et utilisations associées
|
MX2021010603A
(es)
|
2019-03-07 |
2022-01-31 |
Conatus Pharmaceuticals Inc |
Inhibidores de caspasa y metodos de uso de los mismos.
|
JP2022532924A
(ja)
|
2019-05-20 |
2022-07-20 |
ニルバナ サイエンシーズ インク. |
発光波長の範囲が狭い発光染料、それを含む組成物及びそれを製造及び使用する方法
|
US20220274921A1
(en)
|
2019-07-11 |
2022-09-01 |
Cura Therapeutics, Llc |
Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
US20220274922A1
(en)
|
2019-07-11 |
2022-09-01 |
Cura Therapeutics, Llc |
Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications
|
US10940141B1
(en)
|
2019-08-23 |
2021-03-09 |
Neurocrine Biosciences, Inc. |
Methods for the administration of certain VMAT2 inhibitors
|
KR20220053007A
(ko)
|
2019-08-30 |
2022-04-28 |
아게누스 인코포레이티드 |
항-cd96 항체 및 이의 사용 방법
|
CA3154608A1
(en)
|
2019-09-16 |
2021-03-25 |
Dice Alpha, Inc. |
Il-17a modulators and uses thereof
|
KR20220150274A
(ko)
|
2020-01-13 |
2022-11-10 |
네오이뮨텍, 인코퍼레이티드 |
Il-7 단백질과 이중특이적 항체의 조합물을 사용한 종양의 치료 방법
|
WO2021151001A1
(en)
|
2020-01-22 |
2021-07-29 |
Outpace Bio, Inc. |
Chimeric polypeptides
|
KR20220137630A
(ko)
|
2020-02-05 |
2022-10-12 |
워싱턴 유니버시티 |
Il-7 단백질과 car-보유 면역 세포의 조합물로 고형 종양을 치료하는 방법
|
WO2021242970A1
(en)
|
2020-05-29 |
2021-12-02 |
Boulder Bioscience Llc |
Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane
|
EP4168414A1
(de)
|
2020-06-18 |
2023-04-26 |
Shy Therapeutics LLC |
Substituierte thienopyrimidine zur interaktion mit der ras-superfamilie zur behandlung von krebs, entzündlichen erkrankungen, rasopathien und fibrotischen erkrankungen
|
CN111729093B
(zh)
*
|
2020-06-29 |
2022-05-24 |
南京超维景生物科技有限公司 |
一种造影剂成膜剂组合物、造影剂成膜脂液、造影剂及其制备方法
|
CN111617267A
(zh)
*
|
2020-07-07 |
2020-09-04 |
南京大学 |
一种包载全氟化碳的纳米级超声造影剂
|
US20240025863A1
(en)
|
2020-09-16 |
2024-01-25 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2022087335A1
(en)
|
2020-10-23 |
2022-04-28 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
EP4236989A1
(de)
|
2020-11-02 |
2023-09-06 |
NeoImmuneTech, Inc. |
Verwendung von interleukin-7 zur behandlung des coronavirus
|
US20240115675A1
(en)
|
2020-11-05 |
2024-04-11 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccine
|
KR20230157936A
(ko)
|
2020-12-14 |
2023-11-17 |
바이오테릭스, 인코포레이티드 |
Pde4 분해인자, 약제학적 조성물, 및 치료학적 적용
|
WO2022165000A1
(en)
|
2021-01-27 |
2022-08-04 |
Shy Therapeutics, Llc |
Methods for the treatment of fibrotic disease
|
EP4284377A1
(de)
|
2021-01-27 |
2023-12-06 |
Shy Therapeutics LLC |
Verfahren zur behandlung von fibrotischen erkrankungen
|
EP4304716A1
(de)
|
2021-03-10 |
2024-01-17 |
Dice Molecules Sv, Inc. |
Alpha-v-beta-6- und alpha-v-beta-1-integrinhemmer und verwendungen davon
|
EP4326721A1
(de)
|
2021-04-22 |
2024-02-28 |
Protego Biopharma, Inc. |
Spirocyclische imidazolidinone und imidazolidindione zur behandlung von leichtkettiger amyloidose
|
EP4347568A1
(de)
|
2021-05-27 |
2024-04-10 |
Protego Biopharma, Inc. |
Heteroaryldiamid-ire1/xbp1s-aktivatoren
|
WO2022251644A1
(en)
|
2021-05-28 |
2022-12-01 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
WO2022256437A1
(en)
|
2021-06-02 |
2022-12-08 |
Lyell Immunopharma, Inc. |
Nr4a3-deficient immune cells and uses thereof
|
AU2022293999A1
(en)
|
2021-06-14 |
2023-11-30 |
argenx BV |
Anti-il-9 antibodies and methods of use thereof
|
WO2022266249A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2022266248A1
(en)
|
2021-06-16 |
2022-12-22 |
Biotheryx, Inc. |
Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
|
WO2023055045A1
(ko)
|
2021-09-29 |
2023-04-06 |
주식회사 엔바이오스 |
코일드 코일 융합 단백질
|
WO2023081923A1
(en)
|
2021-11-08 |
2023-05-11 |
Frequency Therapeutics, Inc. |
Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
|
WO2023130081A1
(en)
|
2021-12-30 |
2023-07-06 |
Neoimmunetech, Inc. |
Method of treating a tumor with a combination of il-7 protein and vegf antagonist
|
US11932665B2
(en)
|
2022-01-03 |
2024-03-19 |
Lilac Therapeutics, Inc. |
Cyclic thiol prodrugs
|
TW202342070A
(zh)
|
2022-03-30 |
2023-11-01 |
美商拜奧馬林製藥公司 |
肌萎縮蛋白外顯子跳躍寡核苷酸
|
GB2619907A
(en)
|
2022-04-01 |
2023-12-27 |
Kanna Health Ltd |
Novel crystalline salt forms of mesembrine
|
WO2023201282A1
(en)
|
2022-04-14 |
2023-10-19 |
Bristol-Myers Squibb Company |
Novel gspt1 compounds and methods of use of the novel compounds
|
US20230416741A1
(en)
|
2022-05-05 |
2023-12-28 |
Biomarin Pharmaceutical Inc. |
Method of treating duchenne muscular dystrophy
|
WO2023220640A1
(en)
|
2022-05-10 |
2023-11-16 |
Biotheryx, Inc. |
Cdk protein degraders, pharmaceutical compositions, and therapeutic applications
|
WO2023225665A1
(en)
|
2022-05-19 |
2023-11-23 |
Lyell Immunopharma, Inc. |
Polynucleotides targeting nr4a3 and uses thereof
|
WO2024054832A1
(en)
|
2022-09-09 |
2024-03-14 |
Innovo Therapeutics, Inc. |
CK1α AND DUAL CK1α / GSPT1 DEGRADING COMPOUNDS
|
WO2024073473A1
(en)
|
2022-09-30 |
2024-04-04 |
Boulder Bioscience Llc |
Compositions comprising 3,3'-diindolylmethane for treating non-hemorrhagic closed head injury
|